Speaker: Rebecca Soto, Ph.D. Scientist II/Associate Manager Content Marketing, Biocytogen Boston

• Provided a brief overview on molecular mechanisms driving disease progression.
• Discussed modeling inflammatory diseases in wild-type and humanized mice, including psoriasis, atopic dermatitis, delayed type hypersensitivity, inflammatory bowel disease and experimental autoimmune encephalomyelitis.
• Evaluated in vivo efficacy of therapeutic agents in preclinical inflammatory disease mouse models.